
Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial
Publication
, Conference
Asberg, S; Hijazi, Z; Siegbahn, A; Andersson, U; Granger, CB; Hanna, M; Horowitz, JD; Lopes, RD; Lindahl, B; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
September 1, 2014
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
September 1, 2014
Volume
35
Start / End Page
426 / 426
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
Annual Meeting of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Asberg, S., Hijazi, Z., Siegbahn, A., Andersson, U., Granger, C. B., Hanna, M., … Wallentin, L. (2014). Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 35, pp. 426–426). Barcelona, SPAIN: OXFORD UNIV PRESS.
Asberg, S., Z. Hijazi, A. Siegbahn, U. Andersson, C. B. Granger, M. Hanna, J. D. Horowitz, R. D. Lopes, B. Lindahl, and L. Wallentin. “Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 35:426–426. OXFORD UNIV PRESS, 2014.
Asberg S, Hijazi Z, Siegbahn A, Andersson U, Granger CB, Hanna M, et al. Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2014. p. 426–426.
Asberg, S., et al. “Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 35, OXFORD UNIV PRESS, 2014, pp. 426–426.
Asberg S, Hijazi Z, Siegbahn A, Andersson U, Granger CB, Hanna M, Horowitz JD, Lopes RD, Lindahl B, Wallentin L. Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2014. p. 426–426.

Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
September 1, 2014
Volume
35
Start / End Page
426 / 426
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
Annual Meeting of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology